Patent ID: 8501733
Filing Date: 2013-08-06
Classification: A61P,C07D

Abstract:
1. A compound represented by the formula (I): or a pharmaceutically acceptable salt thereof, wherein Ring A is a C6-10 aryl group or a 5- to 10-membered heterocyclic group, L is a single bond, an oxygen atom or a group represented by the formula —C(═O)NR Ring B is a C3-8 cycloalkyl group, a C6-10 aryl group or a 5- to 10-membered heterocyclic group, X is a C1-3 alkylene group or a C2-3 alkenylene group which may have 1 to 3 substituents selected from Substituent Group α, respectively, Y is an oxygen atom, a sulfur atom, a sulfoxide group, a sulfone group or a group represented by the formula —NR Z is a single bond or a C1-3 alkylene group, R R R R n is an integer of 1 to 3 [Substituent Group α: a hydrogen atom, a halogen atom, a hydroxy group, an oxo group, a cyano group, a C1-6 alkyl group, a trifluoromethyl group, a trifluoromethoxy group, a C1-6 alkoxy group, a C3-8 cycloalkyl group, a C3-8 cycloalkyloxy group, a C6-10 aryl group and a 5- to 10-membered heterocyclic group].